EGR2 (also known as Krox-20) is a C2H2-type zinc finger transcription factor belonging to the early growth response (EGR) family. Its primary, best-characterized function is as a master transcriptional regulator of myelination in Schwann cells of the peripheral nervous system, where it activates myelin structural genes (MPZ, PMP22, GJB1, MAG) in cooperation with SOX10. EGR2 binds GC-rich consensus DNA sequences through three C2H2 zinc finger domains and recruits the corepressors NAB1 and NAB2 to modulate transcriptional output. It also has an experimentally demonstrated E3 SUMO ligase activity, catalyzing SUMO1 conjugation to its own NAB coregulators via interaction with UBC9 (PMID:21836637). EGR2 plays critical roles in hindbrain segmentation (specifying rhombomeres 3 and 5 through regulation of HOX genes) and in immune tolerance (T cell anergy, NK cell dysfunction). Mutations in EGR2, particularly in the zinc finger domains, cause Charcot-Marie-Tooth disease type 1D, Dejerine-Sottas syndrome, and congenital hypomyelinating neuropathy.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0000978
RNA polymerase II cis-regulatory region sequence-specific DNA binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: EGR2 is a well-established C2H2 zinc finger transcription factor that binds specific GC-rich cis-regulatory sequences in RNA pol II-transcribed genes. IBA annotation supported by phylogenetic inference across the EGR/Krox/Sp family is consistent with extensive experimental evidence (PMID:17717711, PMID:12687019, PMID:28473536).
Reason: Core molecular function of EGR2 as a sequence-specific DNA-binding TF. EGR2 binds GC-rich EGR consensus sites (e.g. 5'-GCGGGGGCG-3') via its zinc fingers. This IBA annotation is well supported by direct experimental evidence from multiple studies.
Supporting Evidence:
PMID:9537424
Egr2, (also known as Krox20) ... encoding a protein that binds DNA in a sequence-specific manner and acts as a transcription factor
PMID:14532282
Krox20, a zinc finger transcription factor required for Schwann cell differentiation
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: EGR2/Krox-20 is a bona fide DNA-binding transcription factor that activates RNA polymerase II-dependent transcription of target genes including myelin genes and HOX genes. IBA annotation well supported phylogenetically and experimentally.
Reason: Core molecular function. EGR2 directly binds DNA and activates pol II transcription. This is the primary molecular function of EGR2 and is supported by IDA evidence from PMID:17717711 and PMID:12687019, as well as the TFClass database annotation.
Supporting Evidence:
PMID:17717711
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies
PMID:14532282
Krox20, a zinc finger transcription factor required for Schwann cell differentiation, ... showed a strong requirement for functional HCF-1 to activate transcription
|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: EGR2 functions as a nuclear transcription factor. IBA annotation is fully consistent with UniProt subcellular localization and all functional evidence placing EGR2 in the nucleus where it binds DNA and regulates transcription.
Reason: Core localization. EGR2 is a nuclear TF. UniProt states "Nucleus" as subcellular location. All evidence from functional studies and the Reactome pathway annotations place EGR2 in the nucleoplasm.
Supporting Evidence:
PMID:14532282
Krox20, a zinc finger transcription factor required for Schwann cell differentiation
|
|
GO:0006357
regulation of transcription by RNA polymerase II
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: EGR2 is directly involved in regulation of RNA pol II transcription. This IBA annotation at a general level captures the core biological process role of EGR2 as a transcription factor. More specific annotations (positive regulation) are also present.
Reason: Core biological process. EGR2 regulates pol II transcription of myelin genes (MPZ, PMP22, GJB1, MAG), HOX genes, BNIP3L/BAK (PMID:12687019), and lipid biosynthesis genes. This broad term is appropriate for the IBA level.
Supporting Evidence:
PMID:12687019
EGR2 could induce apoptosis in a large proportion of these lines ... EGR2 directly transactivates expression of BNIP3L and BAK
|
|
GO:0003677
DNA binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for DNA binding based on UniProt keyword mapping. EGR2 has three C2H2 zinc finger domains that mediate sequence-specific DNA binding. This is a broad parent term of the more specific cis-regulatory region binding terms.
Reason: Correct but general. More specific terms (GO:0000978, GO:1990837) are also annotated. This IEA is acceptable as a broader annotation consistent with the more specific experimental evidence.
Supporting Evidence:
PMID:9537424
encoding a protein that binds DNA in a sequence-specific manner
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for nucleus based on combined automated methods including ortholog mapping from mouse Egr2. Consistent with all other evidence.
Reason: Correct. Duplicates the IBA annotation but with different evidence code. EGR2 is a nuclear protein.
|
|
GO:0005654
nucleoplasm
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation for nucleoplasm from ARBA machine learning. Consistent with EGR2 being a nuclear transcription factor. Also supported by multiple Reactome TAS annotations for nucleoplasm.
Reason: Correct. As a nuclear transcription factor, EGR2 functions in the nucleoplasm.
|
|
GO:0008270
zinc ion binding
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation based on UniProt keyword "Zinc". EGR2 contains three C2H2-type zinc finger domains (residues 340-364, 370-392, 398-420) that coordinate zinc ions for structural integrity and DNA binding.
Reason: Correct. The three C2H2 zinc fingers are structurally essential for EGR2 DNA-binding function. Disease-causing mutations cluster in these zinc finger domains.
|
|
GO:0016740
transferase activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation based on UniProt keyword "Transferase". This reflects the E3 SUMO ligase activity of EGR2, which catalyzes transfer of SUMO1 to NAB1/NAB2 (PMID:21836637). The term is very broad.
Reason: Technically correct as a parent term of SUMO ligase activity (GO:0061665). The SUMO transferase activity is a child of transferase activity. While broad, this IEA mapping from the Transferase keyword is acceptable.
Supporting Evidence:
PMID:21836637
we show that Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins
|
|
GO:0046872
metal ion binding
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation based on UniProt keyword "Metal-binding". Broad parent of zinc ion binding.
Reason: Correct but very general. The more specific GO:0008270 (zinc ion binding) is also annotated. Acceptable as an IEA parent annotation.
|
|
GO:0000976
transcription cis-regulatory region binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara ortholog transfer (from mouse Egr2). EGR2 binds cis-regulatory regions in target gene promoters and enhancers. Consistent with more specific annotations.
Reason: Correct. Parent term of the more specific GO:0000978. EGR2 binds cis-regulatory elements of myelin genes, HOX genes, and other targets.
|
|
GO:0000978
RNA polymerase II cis-regulatory region sequence-specific DNA binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. Duplicates the IBA annotation. Consistent with experimental evidence.
Reason: Correct. Duplicates IBA and IDA annotations for the same term. Acceptable.
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. Duplicates the IBA and IDA annotations for this core function.
Reason: Correct. Same core function captured by higher-quality evidence codes.
|
|
GO:0003682
chromatin binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 binds chromatin at specific regulatory elements. This is consistent with its role as a transcription factor that binds DNA in a chromatin context.
Reason: Reasonable. As a TF that binds cis-regulatory elements in vivo, EGR2 necessarily interacts with chromatin. Also supported by ISS annotation from the same term.
|
|
GO:0003700
DNA-binding transcription factor activity
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. Parent term of the more specific pol II-specific annotation. Consistent with all evidence.
Reason: Correct. Broader parent of GO:0000981. Also annotated with IDA (PMID:14532282).
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara for cytoplasmic localization. EGR2 is primarily nuclear, but some evidence from mouse orthologs suggests transient cytoplasmic presence, possibly related to nuclear export. UniProt annotates nuclear export for the mouse ortholog.
Reason: EGR2 is primarily a nuclear protein. Cytoplasmic localization may reflect transient shuttling or the protein before nuclear import, but this is not the primary site of function. Keeping as non-core.
|
|
GO:0006611
protein export from nucleus
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara for nuclear export. This is transferred from mouse Egr2 where there is ISS-level evidence. Nuclear export may relate to regulation of EGR2 activity or turnover.
Reason: Not a core function. EGR2 activity is fundamentally nuclear. Nuclear export may be a regulatory mechanism but is not well characterized for human EGR2. Keeping as non-core.
|
|
GO:0014040
positive regulation of Schwann cell differentiation
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 is a master regulator of Schwann cell myelination and promotes Schwann cell differentiation to the myelinating state. This is one of the best-characterized functions of EGR2.
Reason: Core biological process. EGR2/Krox-20 knockout mice show a block in Schwann cell differentiation. EGR2 mutations in humans cause demyelinating neuropathies. Also supported by ISS annotation.
Supporting Evidence:
PMID:9537424
Stable expression of Egr2 is specifically associated with the onset of myelination in the peripheral nervous system (PNS). Egr2(-/-) mice display disrupted hindbrain segmentation and development, and a block of Schwann-cell differentiation at an early stage
|
|
GO:0016925
protein sumoylation
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation from combined automated methods. EGR2 functions as an E3 SUMO ligase for NAB1/NAB2 coregulators (PMID:21836637). The protein sumoylation process annotation is consistent with this enzymatic activity.
Reason: Correct. EGR2 catalyzes SUMO1 conjugation to NAB proteins. This is an experimentally validated function (PMID:21836637) and is appropriately reflected in this process annotation.
Supporting Evidence:
PMID:21836637
Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins--and that Nab sumoylation negatively modulates Krox20 transcriptional activity in vivo
|
|
GO:0021612
facial nerve structural organization
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara. EGR2 is expressed in rhombomeres 3 and 5 during hindbrain development, and Egr2 knockout mice show defects in cranial nerve organization including the facial nerve.
Reason: Developmental role. EGR2 regulates hindbrain segmentation and thereby influences cranial nerve patterning, including the facial nerve. This is a downstream developmental consequence rather than a direct molecular function. Keeping as non-core.
Supporting Evidence:
PMID:17717711
respiratory compromise and cranial nerve dysfunction are commonly associated with EGR2 mutations
|
|
GO:0021659
rhombomere 3 structural organization
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara. EGR2/Krox-20 is specifically expressed in rhombomeres 3 and 5 and is required for their proper specification. This is a core developmental function of EGR2.
Reason: Important developmental function. EGR2 specifies odd rhombomeres by controlling HOX gene expression. This is a well-established role from Egr2 knockout studies but represents a developmental consequence of its TF activity rather than a direct molecular function. Keeping as non-core because it is a downstream developmental process.
|
|
GO:0021665
rhombomere 5 structural organization
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara. Like rhombomere 3, EGR2 is also required for rhombomere 5 organization during hindbrain development.
Reason: Same rationale as rhombomere 3 organization. Well-established developmental role but downstream of core TF activity.
|
|
GO:0031643
positive regulation of myelination
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 is a master positive regulator of peripheral myelination, activating myelin gene expression.
Reason: Core biological process function. EGR2 is the key transcription factor driving peripheral myelination. Its loss causes demyelinating neuropathies. Also supported by ISS annotation.
Supporting Evidence:
PMID:9537424
Stable expression of Egr2 is specifically associated with the onset of myelination in the peripheral nervous system
|
|
GO:0035904
aorta development
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara. EGR2 has been implicated in vascular smooth muscle and aorta development in mouse knockout studies, but this is not a well-characterized function for human EGR2.
Reason: Peripheral function. EGR2 expression is induced by growth factors and may play roles in multiple tissues including vasculature, but this is not a core function. Mouse knockout evidence is the primary support. Keeping as non-core.
|
|
GO:0043565
sequence-specific DNA binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 binds specific GC-rich DNA consensus sequences through its zinc finger domains.
Reason: Correct. Parent of more specific terms. Also annotated with IDA (PMID:17717711).
|
|
GO:0045444
fat cell differentiation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation from Ensembl Compara. Mouse Egr2 has been implicated in adipogenesis, possibly through regulation of CEBPB. This is a secondary function for the human ortholog.
Reason: Peripheral function. While EGR2 may play a role in adipocyte differentiation (UniProt mentions this by similarity), this is not a core function. The primary roles are in myelination and hindbrain development.
|
|
GO:0045893
positive regulation of DNA-templated transcription
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 positively regulates transcription of target genes. Consistent with its role as a transcriptional activator.
Reason: Correct. EGR2 is primarily a transcriptional activator. This is a broad parent of the more specific pol II-specific positive regulation terms.
|
|
GO:0061629
RNA polymerase II-specific DNA-binding transcription factor binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 interacts with other transcription factors and coregulators, including HCFC1 (PMID:14532282), NAB1/NAB2, and SOX10.
Reason: Correct. EGR2 binds to other TF-related proteins. HCFC1 interaction is experimentally validated (PMID:14532282). NAB1/NAB2 interactions are central to EGR2 function.
Supporting Evidence:
PMID:14532282
Krox20, a zinc finger transcription factor required for Schwann cell differentiation, and E2F4, a cell cycle regulator, showed a strong requirement for functional HCF-1 to activate transcription
|
|
GO:0061665
SUMO ligase activity
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. EGR2 has experimentally demonstrated E3 SUMO ligase activity (PMID:21836637), catalyzing SUMO1 conjugation to NAB coregulators.
Reason: Correct. SUMO ligase activity is experimentally validated. EGR2 interacts with UBC9 and facilitates SUMO transfer to NAB1/NAB2. Also annotated with ISS evidence.
Supporting Evidence:
PMID:21836637
Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins
|
|
GO:1990837
sequence-specific double-stranded DNA binding
|
IDA
PMID:28473536 Impact of cytosine methylation on DNA binding specificities ... |
ACCEPT |
Summary: IDA annotation from a systematic high-throughput SELEX study (Yin et al. 2017) that characterized DNA binding specificities of 542 human TFs. EGR2 was among the TFs analyzed for binding to both unmethylated and CpG-methylated DNA.
Reason: Well-supported by high-throughput systematic analysis of TF binding specificities. EGR2 binds dsDNA in a sequence-specific manner through its C2H2 zinc fingers. The SELEX assay directly measures dsDNA binding.
Supporting Evidence:
PMID:28473536
By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment), we found that there are also many TFs that prefer CpG-methylated sequences
|
|
GO:0045944
positive regulation of transcription by RNA polymerase II
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2 (P08152). EGR2 positively regulates pol II transcription. Also supported by IDA annotations from PMID:17717711 and PMID:12687019.
Reason: Core function. ISS is consistent with IDA evidence from the same gene product.
|
|
GO:0014037
Schwann cell differentiation
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 is essential for Schwann cell differentiation from the premyelinating to myelinating state.
Reason: Core biological process. Egr2 knockout mice show a complete block in Schwann cell differentiation. Human EGR2 mutations cause demyelinating neuropathies confirming this conserved function.
Supporting Evidence:
PMID:9537424
Egr2(-/-) mice display disrupted hindbrain segmentation and development, and a block of Schwann-cell differentiation at an early stage
|
|
GO:0014040
positive regulation of Schwann cell differentiation
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 positively drives Schwann cell differentiation toward the myelinating phenotype.
Reason: Core function. Duplicates the IEA annotation with higher-quality ISS evidence.
|
|
GO:0021612
facial nerve structural organization
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferred from mouse Egr2. EGR2 is required for proper facial nerve patterning during hindbrain development.
Reason: Developmental consequence. Consistent with IEA annotation. Cranial nerve dysfunction is a clinical feature of EGR2 mutations (PMID:17717711).
Supporting Evidence:
PMID:17717711
respiratory compromise and cranial nerve dysfunction are commonly associated with EGR2 mutations
|
|
GO:0021659
rhombomere 3 structural organization
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferred from mouse Egr2. Egr2 is expressed in r3 and r5 and is required for their specification.
Reason: Developmental process. Duplicates IEA annotation with higher-quality ISS evidence. EGR2 specifies rhombomere identity through HOX gene regulation.
|
|
GO:0021665
rhombomere 5 structural organization
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferred from mouse Egr2. Same rationale as rhombomere 3.
Reason: Developmental process. Consistent with EGR2 expression in r5 and its role in hindbrain segmentation.
|
|
GO:0031643
positive regulation of myelination
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 is the master positive regulator of peripheral myelination.
Reason: Core function. Duplicates IEA annotation with higher-quality ISS evidence.
|
|
GO:0035914
skeletal muscle cell differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferred from mouse Egr2. There is some evidence from mouse studies for EGR2 involvement in jaw opener musculature development, but this is not well characterized for human EGR2.
Reason: Peripheral function. UniProt mentions a role in jaw opener musculature development by similarity. This is not a core function and evidence in human is limited.
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
IDA
PMID:17717711 Functional, histopathologic and natural history study of neu... |
ACCEPT |
Summary: IDA annotation based on Szigeti et al. 2007, which characterized EGR2 mutations functionally, demonstrating that wild-type EGR2 has DNA-binding transcription factor activity and that disease mutations abolish this activity.
Reason: Core molecular function supported by direct assay. The R359W and E412K mutations caused loss of DNA binding and transactivation activity, confirming WT EGR2 has this function.
Supporting Evidence:
PMID:17717711
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies
|
|
GO:0043565
sequence-specific DNA binding
|
IDA
PMID:17717711 Functional, histopathologic and natural history study of neu... |
ACCEPT |
Summary: IDA annotation from functional characterization of EGR2 mutations. Disease mutations in zinc finger domains abolished sequence-specific DNA binding, confirming wild-type EGR2 binds DNA in a sequence-specific manner.
Reason: Core molecular function. Direct assay evidence from functional studies of disease variants.
|
|
GO:0045944
positive regulation of transcription by RNA polymerase II
|
IDA
PMID:17717711 Functional, histopathologic and natural history study of neu... |
ACCEPT |
Summary: IDA annotation from functional characterization of EGR2. Wild-type EGR2 activates pol II transcription; disease mutations cause loss of transactivation activity.
Reason: Core function. Disease mutations (R359W, E412K) lost transactivation activity, confirming WT EGR2 positively regulates pol II transcription.
|
|
GO:0000785
chromatin
|
ISA
GO_REF:0000113 |
ACCEPT |
Summary: ISA annotation from TFClass database (tfclass:2.3.1, C2H2 zinc finger factors). As a DNA-binding transcription factor, EGR2 localizes to chromatin at its target sites.
Reason: Reasonable. TF annotation from TFClass. EGR2 binds to chromatin at cis-regulatory elements of target genes.
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
ISA
GO_REF:0000113 |
ACCEPT |
Summary: ISA annotation from TFClass database classification of EGR2 as a C2H2 zinc finger transcription factor (class 2.3.1).
Reason: Core function. TFClass annotation consistent with all experimental evidence.
|
|
GO:0016925
protein sumoylation
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 participates in protein sumoylation as an E3 SUMO ligase for NAB1/NAB2.
Reason: Correct. Experimentally validated in PMID:21836637. The ISS annotation from mouse is consistent with human experimental evidence.
Supporting Evidence:
PMID:21836637
Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins
|
|
GO:0061665
SUMO ligase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 has E3 SUMO ligase activity, transferring SUMO1 to NAB coregulators via UBC9.
Reason: Core enzymatic function. Experimentally demonstrated in PMID:21836637 using human Krox20. UniProt lists this as a confirmed activity with EC number.
Supporting Evidence:
PMID:21836637
we show that Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins--and that Nab sumoylation negatively modulates Krox20 transcriptional activity in vivo
|
|
GO:0000978
RNA polymerase II cis-regulatory region sequence-specific DNA binding
|
IDA
PMID:12687019 EGR2 induces apoptosis in various cancer cell lines by direc... |
ACCEPT |
Summary: IDA annotation from Unoki and Nakamura 2003, which showed EGR2 directly binds promoter regions of BNIP3L and BAK to transactivate their expression.
Reason: Core function. Direct assay evidence showing EGR2 binds cis-regulatory regions of target genes and activates transcription.
Supporting Evidence:
PMID:12687019
EGR2 directly transactivates expression of BNIP3L and BAK
|
|
GO:0001228
DNA-binding transcription activator activity, RNA polymerase II-specific
|
IDA
PMID:12687019 EGR2 induces apoptosis in various cancer cell lines by direc... |
ACCEPT |
Summary: IDA annotation for transcription activator activity from the study showing EGR2 directly transactivates BNIP3L and BAK expression.
Reason: Core molecular function. This is a more specific child of GO:0000981 and accurately captures EGR2's role as a transcriptional activator. Consistent with the GO annotation guidelines for DNA-binding transcription factors.
Supporting Evidence:
PMID:12687019
EGR2 could induce apoptosis in a large proportion of these lines ... EGR2 directly transactivates expression of BNIP3L and BAK
|
|
GO:0045944
positive regulation of transcription by RNA polymerase II
|
IDA
PMID:12687019 EGR2 induces apoptosis in various cancer cell lines by direc... |
ACCEPT |
Summary: IDA annotation from the same study showing EGR2 positively regulates pol II transcription of BNIP3L and BAK.
Reason: Core function. Direct experimental evidence for transcriptional activation.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9612073 |
ACCEPT |
Summary: TAS annotation from Reactome pathway for NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression. Places EGR2 in the nucleoplasm.
Reason: Correct localization. EGR2 functions in the nucleoplasm as a transcription factor.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9612483 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR1,2,3 binding the NAB2 promoter. EGR2 binds the NAB2 promoter in the nucleoplasm.
Reason: Correct. EGR2 regulates NAB2 expression as part of a negative feedback loop.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9613210 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR1, EGR2 binding the RRAD promoter.
Reason: Correct localization for nucleoplasmic transcription factor activity.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9613213 |
ACCEPT |
Summary: TAS annotation from Reactome for NAB2 and CHD4 binding and repressing EGR-mediated RRAD gene expression.
Reason: Correct. EGR2-mediated transcription occurs in the nucleoplasm, and NAB2/CHD4 repress this activity.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9613476 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2:NAB2 and CHD4 binding the ID2 and ID4 promoter regions.
Reason: Correct localization for EGR2 transcriptional activity.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9613760 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2 gene expression.
Reason: Correct. EGR2 protein functions in the nucleoplasm.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9616116 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2 and SOX10 binding the MAG gene. This represents a well-characterized myelin gene target.
Reason: Correct. EGR2 cooperates with SOX10 to activate myelin gene expression in the nucleoplasm.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9618559 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2, SOX10 and TEAD1 binding enhancers in the PMP22 gene.
Reason: Correct. PMP22 is a key myelin gene regulated by EGR2.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9618725 |
ACCEPT |
Summary: TAS annotation from Reactome for SOX10, EGR2 and NAB proteins binding the GJB1 promoter.
Reason: Correct. GJB1 (connexin 32) is another myelin gene target of EGR2.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9621400 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2 and SREBF2 dimer binding SCD5 gene.
Reason: Correct. EGR2 cooperates with SREBF2 to regulate lipid biosynthesis genes important for myelin formation.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9621406 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2 and SREBF2 dimer binding CYP51A1 gene.
Reason: Correct. Another lipid biosynthesis gene regulated by EGR2 for myelin formation.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-9621411 |
ACCEPT |
Summary: TAS annotation from Reactome for EGR2 and SREBF2(1-484) dimer binding HMGCR gene.
Reason: Correct. HMGCR encodes a cholesterol biosynthesis enzyme important for myelin lipid composition.
|
|
GO:0000976
transcription cis-regulatory region binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 binds cis-regulatory regions in promoters and enhancers of target genes.
Reason: Correct. Parent term of more specific DNA binding annotations.
|
|
GO:0003682
chromatin binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferred from mouse Egr2. EGR2 binds chromatin at regulatory elements.
Reason: Correct. EGR2 binds chromatin in the context of regulating target gene expression.
|
|
GO:0005634
nucleus
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for nuclear localization transferred from mouse Egr2.
Reason: Correct. Consistent with all other evidence.
|
|
GO:0005737
cytoplasm
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for cytoplasmic localization from mouse Egr2.
Reason: EGR2 is primarily nuclear. Cytoplasmic localization is likely transient.
|
|
GO:0006611
protein export from nucleus
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for nuclear export from mouse Egr2.
Reason: Not core. Regulatory mechanism rather than primary function.
|
|
GO:0045893
positive regulation of DNA-templated transcription
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for positive regulation of transcription from mouse Egr2.
Reason: Core function. EGR2 is primarily a transcriptional activator.
|
|
GO:0005634
nucleus
|
IC
PMID:14532282 HCF-1 functions as a coactivator for the zinc finger protein... |
ACCEPT |
Summary: IC (inferred by curator) annotation for nuclear localization, inferred from DNA-binding transcription factor activity (GO:0003700) demonstrated in PMID:14532282 (HCF-1 as coactivator for Krox20).
Reason: Correct inference. A DNA-binding transcription factor must be in the nucleus to function.
Supporting Evidence:
PMID:14532282
Krox20, a zinc finger transcription factor required for Schwann cell differentiation, ... showed a strong requirement for functional HCF-1 to activate transcription
|
|
GO:0045444
fat cell differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for fat cell differentiation from mouse Egr2.
Reason: Peripheral function. Not a primary role for human EGR2.
|
|
GO:0061629
RNA polymerase II-specific DNA-binding transcription factor binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for TF binding from mouse Egr2. EGR2 interacts with other TFs and coregulators including SOX10, HCFC1, NAB1/NAB2.
Reason: Correct. EGR2 interacts with multiple TF-related proteins. HCFC1 interaction validated experimentally (PMID:14532282).
|
|
GO:0031625
ubiquitin protein ligase binding
|
IPI
PMID:19651900 The HECT-type E3 ubiquitin ligase AIP2 inhibits activation-i... |
ACCEPT |
Summary: IPI annotation showing EGR2 binds the E3 ubiquitin ligase WWP2 (AIP2, UniProtKB:O00308). WWP2 ubiquitinates EGR2, leading to its proteasomal degradation, which regulates activation-induced T cell death.
Reason: Experimentally validated interaction. EGR2 is a substrate of the ubiquitin ligase WWP2, and this interaction regulates EGR2 stability and consequently FasL expression in T cells.
Supporting Evidence:
PMID:19651900
AIP2 interacts with and promotes ubiquitin-mediated degradation of EGR2, a zinc finger transcription factor that has been found to regulate Fas ligand (FasL) expression during activation-induced T-cell death
|
|
GO:0005515
protein binding
|
IPI
PMID:14532282 HCF-1 functions as a coactivator for the zinc finger protein... |
MODIFY |
Summary: IPI annotation for protein binding with HCFC1 (UniProtKB:P51610). EGR2 contains an HCF-binding motif (DHLY at residues 162-165) that mediates interaction with HCFC1, which functions as a coactivator for EGR2.
Reason: The term "protein binding" (GO:0005515) is too vague and uninformative. The interaction with HCFC1 is functionally significant as a transcriptional coactivation interaction. A more specific term should be used. The RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629) already captures this type of interaction.
Proposed replacements:
RNA polymerase II-specific DNA-binding transcription factor binding
Supporting Evidence:
PMID:14532282
HCF-1 functions as a coactivator for the zinc finger protein Krox20 ... In Krox20, the HCF-binding motif lies within the N-terminal activation domain and mutation of this sequence diminishes both transactivation and association with the HCF-1 beta-propeller
|
|
GO:0003700
DNA-binding transcription factor activity
|
IDA
PMID:14532282 HCF-1 functions as a coactivator for the zinc finger protein... |
ACCEPT |
Summary: IDA annotation from Luciano and Wilson 2003. The study demonstrated EGR2/Krox20 has transcription factor activity using reporter assays and showed that HCFC1 functions as its coactivator.
Reason: Core function. Direct assay evidence. While this is a parent of the more specific GO:0000981, it is acceptable as a separate IDA annotation.
Supporting Evidence:
PMID:14532282
Krox20, a zinc finger transcription factor required for Schwann cell differentiation, ... showed a strong requirement for functional HCF-1 to activate transcription
|
|
GO:0007420
brain development
|
TAS
PMID:9537424 Mutations in the early growth response 2 (EGR2) gene are ass... |
KEEP AS NON CORE |
Summary: TAS annotation for brain development from Warner et al. 1998. EGR2 is involved in hindbrain development through its role in rhombomere specification. Egr2 knockout mice show disrupted hindbrain segmentation.
Reason: Broad developmental term. EGR2 is specifically involved in hindbrain segmentation rather than general brain development. The more specific rhombomere terms capture this role better. Keeping as non-core.
Supporting Evidence:
PMID:9537424
Egr2(-/-) mice display disrupted hindbrain segmentation and development
|
|
GO:0007422
peripheral nervous system development
|
TAS
PMID:9537424 Mutations in the early growth response 2 (EGR2) gene are ass... |
ACCEPT |
Summary: TAS annotation for PNS development from Warner et al. 1998. EGR2 is critical for peripheral nerve myelination. The paper identified EGR2 mutations in patients with hereditary myelinopathies.
Reason: Core biological process. EGR2 is essential for PNS development through its role in Schwann cell myelination. Mutations cause inherited peripheral neuropathies.
Supporting Evidence:
PMID:9537424
Stable expression of Egr2 is specifically associated with the onset of myelination in the peripheral nervous system ... we have identified one recessive and two dominant missense mutations in EGR2 ... in patients with congenital hypomyelinating neuropathy (CHN) and a family with Charcot-Marie-Tooth type 1 (CMT1)
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Title: Functional Annotation of Human EGR2 (UniProt P11161) with Emphasis on Recent Findings
Executive summary
EGR2 (KROX20) is a C2H2 zinc-finger transcription factor that orchestrates Schwann cell myelination programs and contributes to immune cell tolerance/dysfunction states. Recent work (2023–2024) adds lncRNA-mediated chromatin control of EGR2 in Schwann cells and identifies EGR2 as a tractable regulator of NK cell dysfunction in cancer, with therapeutic reprogramming potential. Evidence for EGR2’s canonical DNA-binding, NAB1/2 corepressor interactions, and myelin gene regulation remains strong. Below, we synthesize the identity, molecular functions, mechanisms, disease links, and applications, prioritizing recent sources.
1) Identity verification and core definitions
- Gene/protein: Early Growth Response Protein 2 (EGR2), also known as KROX20; human UniProt P11161. Member of the EGR family with three Cys2-His2 (C2H2) zinc-finger motifs that bind GC-rich consensus sequences as a nuclear transcription factor. Review literature and mechanistic studies consistently identify EGR2 as a zinc-finger TF required in myelinating Schwann cells (aliases Krox-20/Egr-2), aligning with the UniProt family/domain annotation (EGR C2H2-type zinc fingers). (keeton2003insulinregulatedexpressionof pages 1-2, guo2025multifacetedregulatorymechanisms pages 20-21)
URL and date: https://doi.org/10.1210/en.2003-0592 (Dec 2003); https://doi.org/10.3892/ijmm.2025.5554 (May 2025)
2) Primary molecular function and mechanisms
- DNA binding and consensus motif: The EGR family (including EGR2) binds GC-rich EGR sites (canonical consensus exemplified by GCGGGGGCG) via its C-terminal C2H2 zinc fingers. (keeton2003insulinregulatedexpressionof pages 1-2)
URL and date: https://doi.org/10.1210/en.2003-0592 (Dec 2003)
- Co-regulators NAB1/NAB2: EGR2 contains a central domain that interacts with the corepressors NAB1 and NAB2, modulating transcriptional output at target enhancers/promoters. (keeton2003insulinregulatedexpressionof pages 1-2, guo2025multifacetedregulatorymechanisms pages 20-21)
URLs and dates: https://doi.org/10.1210/en.2003-0592 (Dec 2003); https://doi.org/10.3892/ijmm.2025.5554 (May 2025)
- SUMO pathway/E3 SUMO ligase context: Contemporary reviews place EGR2 within broader SUMO-pathway gene signatures in cancer biology, underscoring mechanistic intersections between EGR-family transcriptional control and SUMOylation modules, though direct catalytic EGR2 E3 SUMO ligase activity in human cancer settings remains primarily supported by earlier reports and integrative analyses rather than 2023–2024 primary enzymology. (guo2025multifacetedregulatorymechanisms pages 20-21)
URL and date: https://doi.org/10.3892/ijmm.2025.5554 (May 2025)
3) Subcellular localization
- EGR2 functions as a nuclear transcription factor; its activity is mediated through nuclear DNA binding and interaction with transcriptional co-regulators. (keeton2003insulinregulatedexpressionof pages 1-2)
URL and date: https://doi.org/10.1210/en.2003-0592 (Dec 2003)
4) Schwann cell myelination: programs, targets, and regulation
- Master regulator of myelination: EGR2 is essential for Schwann cell radial sorting and transition to the myelinating state; it integrates upstream axo-glial signals into coordinated activation of myelin gene programs. (ramesh2023theschwanncell pages 32-39)
- Upstream pathways: cAMP–PKA signaling (e.g., via GPR126/ADGRG6) promotes Egr2 induction; YY1 links neuregulin/ERK signaling to Egr2 through binding at the myelinating Schwann cell enhancer (MSE). YAP/TAZ–TEAD coactivators contribute to Egr2 induction and cooperate with SOX10-bound elements. (ramesh2023theschwanncell pages 32-39)
- Antagonistic injury and plasticity programs: cJUN and other injury-induced factors repress Egr2 after nerve injury; conversely, myelination requires repression of inhibitors (e.g., SOX2) via regulators such as ZEB2. (ramesh2023theschwanncell pages 32-39)
- lncRNA regulation: An Egr2 promoter antisense lncRNA (Egr2-AS) is induced after peripheral nerve injury and recruits EZH2 and WDR5 to redistribute H3K27me3/H3K4me3 at EGR2 and C-JUN promoters. Egr2-AS expression is controlled by a Neuregulin–ErbB2/3–YY1Ser184 axis and remodels 3D chromatin architecture (loops, TAD hierarchy) in Schwann cells, providing a mechanism for dynamic EGR2 silencing and injury-associated chromatin reprogramming. (moreno2024roleofthe pages 1-2, moreno2024roleofthe pages 2-4)
URLs and dates: 2023 network review (journal details not provided in record) (ramesh2023theschwanncell pages 32-39); https://doi.org/10.3390/biomedicines12112594 (Nov 2024) (moreno2024roleofthe pages 1-2, moreno2024roleofthe pages 2-4)
5) Human disease relevance: inherited neuropathies
- EGR2 variants cause autosomal dominant and recessive demyelinating neuropathies spanning Charcot–Marie–Tooth disease and Dejerine–Sottas neuropathy; neuropathy-associated EGR2 mutations disrupt cooperative activation of myelin genes (e.g., MPZ/P0) with SOX10, mechanistically explaining myelin failure. Contemporary reviews retain EGR2 among canonical CMT/DSS genes; variant clustering in zinc-finger domains is recurrent in case series. While large cohort frequency statistics specific to EGR2 from 2023–2024 are limited in the present evidence set, the mechanistic and genetic connection remains well supported. (guo2025multifacetedregulatorymechanisms pages 20-21)
URL and date: https://doi.org/10.3892/ijmm.2025.5554 (May 2025)
6) Immune cell functions: anergy, exhaustion, and pathogenic programs
- NK cell dysfunction in cancer and therapeutic reprogramming: Human and mouse studies identify EGR2 as a central node of the NK dysfunction/anergy program. EGR2 upregulates DGKα, converting DAG to PA, which recruits SHP-1, dephosphorylates LAT/PLCγ1/2, and suppresses Ras–MAPK and Ca2+–NFAT signaling, enforcing an anergy-like transcriptional state. siRNA nanoparticle silencing of EGR2 in anergic human NK cells restores cytotoxicity, reduces PD-1, and improves anti-tumor activity in 3D spheroids and in vivo xenograft models, nominating EGR2 as a druggable regulator of NK dysfunction. (sabag2024dysfunctionalnaturalkiller pages 12-13, sabag2024dysfunctionalnaturalkiller pages 12-12)
URL and date: https://doi.org/10.1038/s44318-024-00094-5 (Apr 2024)
- T cell exhaustion/anergy context: Contemporary mechanistic reviews catalog EGR2 among transcription factors associated with anergy/exhaustion circuits in human and mouse T cells, cooperating with NR4A, NFAT, and TOX family factors in establishing or maintaining dysfunctional phenotypes. (keeton2003insulinregulatedexpressionof pages 1-2)
URL and date: https://doi.org/10.1210/en.2003-0592 (Dec 2003)
7) Cancer associations and applications
- Integrative cancer immunology and systems-biology studies implicate EGR-family factors (including EGR2) in tumor biology; recent reviews highlight broad EGR mechanisms in tumors and note links to SUMO-pathway gene signatures with prognostic/therapeutic implications. These findings frame EGR2 as both a potential biomarker and a target for transcription-factor–guided interventions (e.g., immune reprogramming via EGR2 modulation). (guo2025multifacetedregulatorymechanisms pages 20-21, sabag2024dysfunctionalnaturalkiller pages 12-13, sabag2024dysfunctionalnaturalkiller pages 12-12)
URLs and dates: https://doi.org/10.3892/ijmm.2025.5554 (May 2025); https://doi.org/10.1038/s44318-024-00094-5 (Apr 2024)
8) Vascular/endothelial or other tissues
- Insulin and MAPK signaling can induce EGR family transcription in non-neural tissues, underscoring broader context-dependent regulation outside Schwann cells; however, the present evidence set emphasizes neural and immune contexts rather than definitive vascular cell–type maps. (keeton2003insulinregulatedexpressionof pages 1-2)
URL and date: https://doi.org/10.1210/en.2003-0592 (Dec 2003)
Expert analysis and synthesis
- Core biochemical role: EGR2 is best defined as a nuclear C2H2 zinc-finger transcription factor that binds GC-rich EGR motifs and recruits NAB1/2 to activate or repress target genes, positioning it as a master regulator of myelin programs in Schwann cells and a node in immune tolerance/dysfunction circuits. The precision of its action emerges from enhancer logic with SOX10 and coactivators (TEAD/YAP-TAZ), combined with dynamic repression via injury-induced factors and a promoter antisense lncRNA that retools chromatin architecture. (keeton2003insulinregulatedexpressionof pages 1-2, ramesh2023theschwanncell pages 32-39, moreno2024roleofthe pages 1-2, moreno2024roleofthe pages 2-4)
- Recent advances (2023–2024): Egr2-AS establishes a mechanistic bridge from extracellular neuregulin signals to epigenomic remodeling that silences EGR2 and reorganizes 3D genome topology in Schwann cells after injury, refining our understanding of myelin plasticity and repair. In parallel, EGR2 emerges as a therapeutically addressable regulator of NK cell dysfunction in human cancer, with nanoparticle-delivered EGR2 silencing restoring cytotoxicity in preclinical systems—an actionable avenue toward enhancing anti-tumor immunity. (moreno2024roleofthe pages 1-2, moreno2024roleofthe pages 2-4, sabag2024dysfunctionalnaturalkiller pages 12-13, sabag2024dysfunctionalnaturalkiller pages 12-12)
- Clinical implications: For neuropathies, EGR2 remains a high-value diagnostic gene, particularly where variants localize to zinc-finger domains and phenotypes span CMT to Dejerine–Sottas. In oncology/immunotherapy, EGR2-directed reprogramming of dysfunctional NK cells represents an emerging translational strategy to improve outcomes. (guo2025multifacetedregulatorymechanisms pages 20-21, sabag2024dysfunctionalnaturalkiller pages 12-13, sabag2024dysfunctionalnaturalkiller pages 12-12)
Key statistics/data points from recent studies
- NK dysfunction reprogramming: In preclinical models, EGR2 siRNA–nanoparticle treatment of dysfunctional human NK cells in 3D tumor spheroids and xenografts restored degranulation, reduced PD-1 expression, and curtailed tumor growth, with an NK-DGKA-EGR2 transcriptomic signature associating with survival in AML and glioma datasets. (sabag2024dysfunctionalnaturalkiller pages 12-13, sabag2024dysfunctionalnaturalkiller pages 12-12)
URL and date: https://doi.org/10.1038/s44318-024-00094-5 (Apr 2024)
- Schwann cell chromatin remodeling: Overexpression of Egr2-AS in Schwann cells recruited EZH2/WDR5, shifted H3K27me3/H3K4me3 at EGR2/C-JUN promoters, altered enhancer-promoter loop contacts (including inter-TAD loops to an mTOR promoter hub), and changed AP-1 TF footprints—quantitatively documenting chromatin accessibility and 3D genome changes after injury signaling. (moreno2024roleofthe pages 1-2, moreno2024roleofthe pages 2-4)
URL and date: https://doi.org/10.3390/biomedicines12112594 (Nov 2024)
Limitations
- While EGR2’s role in CMT/DSS is well-established, our present evidence set lacks a 2023–2024 cohort publication with precise EGR2-specific prevalence; thus quantitative epidemiology is limited herein. (guo2025multifacetedregulatorymechanisms pages 20-21)
References (URLs and publication dates)
- Keeton AB et al. Insulin-regulated expression of Egr-1 and Krox20. Endocrinology. Dec 2003. https://doi.org/10.1210/en.2003-0592 (keeton2003insulinregulatedexpressionof pages 1-2)
- Ramesh R. The Schwann Cell Regulatory Network in Development and Injury. 2023. (ramesh2023theschwanncell pages 32-39)
- Martinez Moreno M et al. Role of the Egr2 Promoter Antisense RNA in Modulating the Schwann Cell Chromatin Landscape. Biomedicines. Nov 2024. https://doi.org/10.3390/biomedicines12112594 (moreno2024roleofthe pages 1-2, moreno2024roleofthe pages 2-4)
- Sabag B et al. Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity. EMBO J. Apr 2024. https://doi.org/10.1038/s44318-024-00094-5 (sabag2024dysfunctionalnaturalkiller pages 12-13, sabag2024dysfunctionalnaturalkiller pages 12-12)
- Guo R et al. Multifaceted regulatory mechanisms of the EGR family in tumours and prospects for therapeutic applications (Review). Int J Mol Med. May 2025. https://doi.org/10.3892/ijmm.2025.5554 (guo2025multifacetedregulatorymechanisms pages 20-21)
References
(keeton2003insulinregulatedexpressionof pages 1-2): Adam B. Keeton, Katherine D. Bortoff, William L. Bennett, J. Lee Franklin, Derwei Y. Venable, and Joseph L. Messina. Insulin-regulated expression of egr-1 and krox20: dependence on erk1/2 and interaction with p38 and pi3-kinase pathways. Endocrinology, 144 12:5402-10, Dec 2003. URL: https://doi.org/10.1210/en.2003-0592, doi:10.1210/en.2003-0592. This article has 97 citations and is from a domain leading peer-reviewed journal.
(guo2025multifacetedregulatorymechanisms pages 20-21): Rongqi Guo, Rui Wang, Weisong Zhang, Yangyang Li, Yihao Wang, Hao Wang, Xia Li, and Jianxiang Song. Multifaceted regulatory mechanisms of the egr family in tumours and prospects for therapeutic applications (review). International Journal of Molecular Medicine, 56:1-26, May 2025. URL: https://doi.org/10.3892/ijmm.2025.5554, doi:10.3892/ijmm.2025.5554. This article has 4 citations and is from a peer-reviewed journal.
(ramesh2023theschwanncell pages 32-39): R Ramesh. The schwann cell regulatory network in development and injury. Unknown journal, 2023.
(moreno2024roleofthe pages 1-2): Margot Martinez Moreno, David Karambizi, Hyeyeon Hwang, Kristen Fregoso, Madison J. Michles, Eduardo Fajardo, Andras Fiser, and Nikos Tapinos. Role of the egr2 promoter antisense rna in modulating the schwann cell chromatin landscape. Biomedicines, 12:2594, Nov 2024. URL: https://doi.org/10.3390/biomedicines12112594, doi:10.3390/biomedicines12112594. This article has 0 citations and is from a poor quality or predatory journal.
(moreno2024roleofthe pages 2-4): Margot Martinez Moreno, David Karambizi, Hyeyeon Hwang, Kristen Fregoso, Madison J. Michles, Eduardo Fajardo, Andras Fiser, and Nikos Tapinos. Role of the egr2 promoter antisense rna in modulating the schwann cell chromatin landscape. Biomedicines, 12:2594, Nov 2024. URL: https://doi.org/10.3390/biomedicines12112594, doi:10.3390/biomedicines12112594. This article has 0 citations and is from a poor quality or predatory journal.
(sabag2024dysfunctionalnaturalkiller pages 12-13): Batel Sabag, Abhishek Puthenveetil, Moria Levy, Noah Joseph, Tirtza Doniger, Orly Yaron, Sarit Karako-Lampert, Itay Lazar, Fatima Awwad, Shahar Ashkenazi, and Mira Barda-Saad. Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity. The EMBO Journal, 43:2552-2581, Apr 2024. URL: https://doi.org/10.1038/s44318-024-00094-5, doi:10.1038/s44318-024-00094-5. This article has 11 citations.
(sabag2024dysfunctionalnaturalkiller pages 12-12): Batel Sabag, Abhishek Puthenveetil, Moria Levy, Noah Joseph, Tirtza Doniger, Orly Yaron, Sarit Karako-Lampert, Itay Lazar, Fatima Awwad, Shahar Ashkenazi, and Mira Barda-Saad. Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity. The EMBO Journal, 43:2552-2581, Apr 2024. URL: https://doi.org/10.1038/s44318-024-00094-5, doi:10.1038/s44318-024-00094-5. This article has 11 citations.
id: P11161
gene_symbol: EGR2
product_type: PROTEIN
status: IN_PROGRESS
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
EGR2 (also known as Krox-20) is a C2H2-type zinc finger transcription factor belonging to the
early growth response (EGR) family. Its primary, best-characterized function is as a master
transcriptional regulator of myelination in Schwann cells of the peripheral nervous system,
where it activates myelin structural genes (MPZ, PMP22, GJB1, MAG) in cooperation with SOX10.
EGR2 binds GC-rich consensus DNA sequences through three C2H2 zinc finger domains and recruits
the corepressors NAB1 and NAB2 to modulate transcriptional output. It also has an experimentally
demonstrated E3 SUMO ligase activity, catalyzing SUMO1 conjugation to its own NAB coregulators
via interaction with UBC9 (PMID:21836637). EGR2 plays critical roles in hindbrain segmentation
(specifying rhombomeres 3 and 5 through regulation of HOX genes) and in immune tolerance
(T cell anergy, NK cell dysfunction). Mutations in EGR2, particularly in the zinc finger domains,
cause Charcot-Marie-Tooth disease type 1D, Dejerine-Sottas syndrome, and congenital
hypomyelinating neuropathy.
alternative_products:
- name: Long
id: P11161-1
- name: Short
id: P11161-2
sequence_note: VSP_006863
existing_annotations:
# ===== IBA annotations =====
- term:
id: GO:0000978
label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
EGR2 is a well-established C2H2 zinc finger transcription factor that binds specific
GC-rich cis-regulatory sequences in RNA pol II-transcribed genes. IBA annotation supported
by phylogenetic inference across the EGR/Krox/Sp family is consistent with extensive
experimental evidence (PMID:17717711, PMID:12687019, PMID:28473536).
action: ACCEPT
reason: >-
Core molecular function of EGR2 as a sequence-specific DNA-binding TF. EGR2 binds
GC-rich EGR consensus sites (e.g. 5'-GCGGGGGCG-3') via its zinc fingers. This IBA
annotation is well supported by direct experimental evidence from multiple studies.
additional_reference_ids:
- file:human/EGR2/EGR2-deep-research-falcon.md
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Egr2, (also known as Krox20) ... encoding a protein that binds DNA in a
sequence-specific manner and acts as a transcription factor
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
EGR2/Krox-20 is a bona fide DNA-binding transcription factor that activates RNA polymerase
II-dependent transcription of target genes including myelin genes and HOX genes. IBA
annotation well supported phylogenetically and experimentally.
action: ACCEPT
reason: >-
Core molecular function. EGR2 directly binds DNA and activates pol II transcription.
This is the primary molecular function of EGR2 and is supported by IDA evidence from
PMID:17717711 and PMID:12687019, as well as the TFClass database annotation.
supported_by:
- reference_id: PMID:17717711
supporting_text: >-
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and
related inherited peripheral neuropathies
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation,
... showed a strong requirement for functional HCF-1 to activate transcription
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
EGR2 functions as a nuclear transcription factor. IBA annotation is fully consistent
with UniProt subcellular localization and all functional evidence placing EGR2 in the
nucleus where it binds DNA and regulates transcription.
action: ACCEPT
reason: >-
Core localization. EGR2 is a nuclear TF. UniProt states "Nucleus" as subcellular location.
All evidence from functional studies and the Reactome pathway annotations place EGR2
in the nucleoplasm.
supported_by:
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation
- term:
id: GO:0006357
label: regulation of transcription by RNA polymerase II
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
EGR2 is directly involved in regulation of RNA pol II transcription. This IBA annotation
at a general level captures the core biological process role of EGR2 as a transcription
factor. More specific annotations (positive regulation) are also present.
action: ACCEPT
reason: >-
Core biological process. EGR2 regulates pol II transcription of myelin genes (MPZ, PMP22,
GJB1, MAG), HOX genes, BNIP3L/BAK (PMID:12687019), and lipid biosynthesis genes.
This broad term is appropriate for the IBA level.
supported_by:
- reference_id: PMID:12687019
supporting_text: >-
EGR2 could induce apoptosis in a large proportion of these lines ... EGR2 directly
transactivates expression of BNIP3L and BAK
# ===== IEA annotations =====
- term:
id: GO:0003677
label: DNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for DNA binding based on UniProt keyword mapping. EGR2 has three C2H2
zinc finger domains that mediate sequence-specific DNA binding. This is a broad parent
term of the more specific cis-regulatory region binding terms.
action: ACCEPT
reason: >-
Correct but general. More specific terms (GO:0000978, GO:1990837) are also annotated.
This IEA is acceptable as a broader annotation consistent with the more specific
experimental evidence.
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
encoding a protein that binds DNA in a sequence-specific manner
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for nucleus based on combined automated methods including ortholog
mapping from mouse Egr2. Consistent with all other evidence.
action: ACCEPT
reason: >-
Correct. Duplicates the IBA annotation but with different evidence code. EGR2 is a nuclear
protein.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation for nucleoplasm from ARBA machine learning. Consistent with EGR2 being
a nuclear transcription factor. Also supported by multiple Reactome TAS annotations
for nucleoplasm.
action: ACCEPT
reason: >-
Correct. As a nuclear transcription factor, EGR2 functions in the nucleoplasm.
- term:
id: GO:0008270
label: zinc ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
IEA annotation based on UniProt keyword "Zinc". EGR2 contains three C2H2-type zinc
finger domains (residues 340-364, 370-392, 398-420) that coordinate zinc ions for
structural integrity and DNA binding.
action: ACCEPT
reason: >-
Correct. The three C2H2 zinc fingers are structurally essential for EGR2 DNA-binding
function. Disease-causing mutations cluster in these zinc finger domains.
- term:
id: GO:0016740
label: transferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
IEA annotation based on UniProt keyword "Transferase". This reflects the E3 SUMO ligase
activity of EGR2, which catalyzes transfer of SUMO1 to NAB1/NAB2 (PMID:21836637).
The term is very broad.
action: ACCEPT
reason: >-
Technically correct as a parent term of SUMO ligase activity (GO:0061665). The
SUMO transferase activity is a child of transferase activity. While broad, this IEA
mapping from the Transferase keyword is acceptable.
supported_by:
- reference_id: PMID:21836637
supporting_text: >-
we show that Krox20 functions as a SUMO ligase for its coregulators--the Nab
proteins
- term:
id: GO:0046872
label: metal ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
IEA annotation based on UniProt keyword "Metal-binding". Broad parent of zinc ion
binding.
action: ACCEPT
reason: >-
Correct but very general. The more specific GO:0008270 (zinc ion binding) is also
annotated. Acceptable as an IEA parent annotation.
- term:
id: GO:0000976
label: transcription cis-regulatory region binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara ortholog transfer (from mouse Egr2). EGR2 binds
cis-regulatory regions in target gene promoters and enhancers. Consistent with more
specific annotations.
action: ACCEPT
reason: >-
Correct. Parent term of the more specific GO:0000978. EGR2 binds cis-regulatory elements
of myelin genes, HOX genes, and other targets.
- term:
id: GO:0000978
label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. Duplicates the IBA annotation. Consistent with
experimental evidence.
action: ACCEPT
reason: >-
Correct. Duplicates IBA and IDA annotations for the same term. Acceptable.
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. Duplicates the IBA and IDA annotations for this
core function.
action: ACCEPT
reason: >-
Correct. Same core function captured by higher-quality evidence codes.
- term:
id: GO:0003682
label: chromatin binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 binds chromatin at specific regulatory
elements. This is consistent with its role as a transcription factor that binds DNA
in a chromatin context.
action: ACCEPT
reason: >-
Reasonable. As a TF that binds cis-regulatory elements in vivo, EGR2 necessarily
interacts with chromatin. Also supported by ISS annotation from the same term.
- term:
id: GO:0003700
label: DNA-binding transcription factor activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. Parent term of the more specific pol II-specific
annotation. Consistent with all evidence.
action: ACCEPT
reason: >-
Correct. Broader parent of GO:0000981. Also annotated with IDA (PMID:14532282).
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara for cytoplasmic localization. EGR2 is primarily
nuclear, but some evidence from mouse orthologs suggests transient cytoplasmic presence,
possibly related to nuclear export. UniProt annotates nuclear export for the mouse
ortholog.
action: KEEP_AS_NON_CORE
reason: >-
EGR2 is primarily a nuclear protein. Cytoplasmic localization may reflect transient
shuttling or the protein before nuclear import, but this is not the primary site of
function. Keeping as non-core.
- term:
id: GO:0006611
label: protein export from nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara for nuclear export. This is transferred from mouse
Egr2 where there is ISS-level evidence. Nuclear export may relate to regulation of EGR2
activity or turnover.
action: KEEP_AS_NON_CORE
reason: >-
Not a core function. EGR2 activity is fundamentally nuclear. Nuclear export may be a
regulatory mechanism but is not well characterized for human EGR2. Keeping as non-core.
- term:
id: GO:0014040
label: positive regulation of Schwann cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 is a master regulator of Schwann cell
myelination and promotes Schwann cell differentiation to the myelinating state. This
is one of the best-characterized functions of EGR2.
action: ACCEPT
reason: >-
Core biological process. EGR2/Krox-20 knockout mice show a block in Schwann cell
differentiation. EGR2 mutations in humans cause demyelinating neuropathies. Also
supported by ISS annotation.
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Stable expression of Egr2 is specifically associated with the onset of myelination
in the peripheral nervous system (PNS). Egr2(-/-) mice display disrupted hindbrain
segmentation and development, and a block of Schwann-cell differentiation at an
early stage
- term:
id: GO:0016925
label: protein sumoylation
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from combined automated methods. EGR2 functions as an E3 SUMO ligase
for NAB1/NAB2 coregulators (PMID:21836637). The protein sumoylation process annotation
is consistent with this enzymatic activity.
action: ACCEPT
reason: >-
Correct. EGR2 catalyzes SUMO1 conjugation to NAB proteins. This is an experimentally
validated function (PMID:21836637) and is appropriately reflected in this process
annotation.
supported_by:
- reference_id: PMID:21836637
supporting_text: >-
Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins--and that
Nab sumoylation negatively modulates Krox20 transcriptional activity in vivo
- term:
id: GO:0021612
label: facial nerve structural organization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 is expressed in rhombomeres 3 and 5 during
hindbrain development, and Egr2 knockout mice show defects in cranial nerve organization
including the facial nerve.
action: KEEP_AS_NON_CORE
reason: >-
Developmental role. EGR2 regulates hindbrain segmentation and thereby influences cranial
nerve patterning, including the facial nerve. This is a downstream developmental
consequence rather than a direct molecular function. Keeping as non-core.
supported_by:
- reference_id: PMID:17717711
supporting_text: >-
respiratory compromise and cranial nerve dysfunction are commonly associated with
EGR2 mutations
- term:
id: GO:0021659
label: rhombomere 3 structural organization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2/Krox-20 is specifically expressed in
rhombomeres 3 and 5 and is required for their proper specification. This is a core
developmental function of EGR2.
action: KEEP_AS_NON_CORE
reason: >-
Important developmental function. EGR2 specifies odd rhombomeres by controlling HOX
gene expression. This is a well-established role from Egr2 knockout studies but
represents a developmental consequence of its TF activity rather than a direct molecular
function. Keeping as non-core because it is a downstream developmental process.
- term:
id: GO:0021665
label: rhombomere 5 structural organization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. Like rhombomere 3, EGR2 is also required for
rhombomere 5 organization during hindbrain development.
action: KEEP_AS_NON_CORE
reason: >-
Same rationale as rhombomere 3 organization. Well-established developmental role but
downstream of core TF activity.
- term:
id: GO:0031643
label: positive regulation of myelination
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 is a master positive regulator of peripheral
myelination, activating myelin gene expression.
action: ACCEPT
reason: >-
Core biological process function. EGR2 is the key transcription factor driving peripheral
myelination. Its loss causes demyelinating neuropathies. Also supported by ISS annotation.
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Stable expression of Egr2 is specifically associated with the onset of myelination
in the peripheral nervous system
- term:
id: GO:0035904
label: aorta development
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 has been implicated in vascular smooth
muscle and aorta development in mouse knockout studies, but this is not a well-characterized
function for human EGR2.
action: KEEP_AS_NON_CORE
reason: >-
Peripheral function. EGR2 expression is induced by growth factors and may play roles
in multiple tissues including vasculature, but this is not a core function. Mouse
knockout evidence is the primary support. Keeping as non-core.
- term:
id: GO:0043565
label: sequence-specific DNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 binds specific GC-rich DNA consensus sequences
through its zinc finger domains.
action: ACCEPT
reason: >-
Correct. Parent of more specific terms. Also annotated with IDA (PMID:17717711).
- term:
id: GO:0045444
label: fat cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. Mouse Egr2 has been implicated in adipogenesis,
possibly through regulation of CEBPB. This is a secondary function for the human ortholog.
action: KEEP_AS_NON_CORE
reason: >-
Peripheral function. While EGR2 may play a role in adipocyte differentiation (UniProt
mentions this by similarity), this is not a core function. The primary roles are in
myelination and hindbrain development.
- term:
id: GO:0045893
label: positive regulation of DNA-templated transcription
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 positively regulates transcription of
target genes. Consistent with its role as a transcriptional activator.
action: ACCEPT
reason: >-
Correct. EGR2 is primarily a transcriptional activator. This is a broad parent of the
more specific pol II-specific positive regulation terms.
- term:
id: GO:0061629
label: RNA polymerase II-specific DNA-binding transcription factor binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 interacts with other transcription factors
and coregulators, including HCFC1 (PMID:14532282), NAB1/NAB2, and SOX10.
action: ACCEPT
reason: >-
Correct. EGR2 binds to other TF-related proteins. HCFC1 interaction is experimentally
validated (PMID:14532282). NAB1/NAB2 interactions are central to EGR2 function.
supported_by:
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation,
and E2F4, a cell cycle regulator, showed a strong requirement for functional HCF-1
to activate transcription
- term:
id: GO:0061665
label: SUMO ligase activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. EGR2 has experimentally demonstrated E3 SUMO
ligase activity (PMID:21836637), catalyzing SUMO1 conjugation to NAB coregulators.
action: ACCEPT
reason: >-
Correct. SUMO ligase activity is experimentally validated. EGR2 interacts with UBC9
and facilitates SUMO transfer to NAB1/NAB2. Also annotated with ISS evidence.
supported_by:
- reference_id: PMID:21836637
supporting_text: >-
Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins
# ===== IDA annotations =====
- term:
id: GO:1990837
label: sequence-specific double-stranded DNA binding
evidence_type: IDA
original_reference_id: PMID:28473536
review:
summary: >-
IDA annotation from a systematic high-throughput SELEX study (Yin et al. 2017) that
characterized DNA binding specificities of 542 human TFs. EGR2 was among the TFs
analyzed for binding to both unmethylated and CpG-methylated DNA.
action: ACCEPT
reason: >-
Well-supported by high-throughput systematic analysis of TF binding specificities. EGR2
binds dsDNA in a sequence-specific manner through its C2H2 zinc fingers. The SELEX
assay directly measures dsDNA binding.
supported_by:
- reference_id: PMID:28473536
supporting_text: >-
By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution
of ligands by exponential enrichment), we found that there are also many TFs
that prefer CpG-methylated sequences
# ===== ISS annotations =====
- term:
id: GO:0045944
label: positive regulation of transcription by RNA polymerase II
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2 (P08152). EGR2 positively regulates pol II
transcription. Also supported by IDA annotations from PMID:17717711 and PMID:12687019.
action: ACCEPT
reason: >-
Core function. ISS is consistent with IDA evidence from the same gene product.
- term:
id: GO:0014037
label: Schwann cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 is essential for Schwann cell
differentiation from the premyelinating to myelinating state.
action: ACCEPT
reason: >-
Core biological process. Egr2 knockout mice show a complete block in Schwann cell
differentiation. Human EGR2 mutations cause demyelinating neuropathies confirming
this conserved function.
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Egr2(-/-) mice display disrupted hindbrain segmentation and development, and a
block of Schwann-cell differentiation at an early stage
- term:
id: GO:0014040
label: positive regulation of Schwann cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 positively drives Schwann cell
differentiation toward the myelinating phenotype.
action: ACCEPT
reason: >-
Core function. Duplicates the IEA annotation with higher-quality ISS evidence.
- term:
id: GO:0021612
label: facial nerve structural organization
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 is required for proper facial nerve
patterning during hindbrain development.
action: KEEP_AS_NON_CORE
reason: >-
Developmental consequence. Consistent with IEA annotation. Cranial nerve dysfunction
is a clinical feature of EGR2 mutations (PMID:17717711).
supported_by:
- reference_id: PMID:17717711
supporting_text: >-
respiratory compromise and cranial nerve dysfunction are commonly associated with
EGR2 mutations
- term:
id: GO:0021659
label: rhombomere 3 structural organization
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. Egr2 is expressed in r3 and r5 and is
required for their specification.
action: KEEP_AS_NON_CORE
reason: >-
Developmental process. Duplicates IEA annotation with higher-quality ISS evidence.
EGR2 specifies rhombomere identity through HOX gene regulation.
- term:
id: GO:0021665
label: rhombomere 5 structural organization
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. Same rationale as rhombomere 3.
action: KEEP_AS_NON_CORE
reason: >-
Developmental process. Consistent with EGR2 expression in r5 and its role in hindbrain
segmentation.
- term:
id: GO:0031643
label: positive regulation of myelination
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 is the master positive regulator of
peripheral myelination.
action: ACCEPT
reason: >-
Core function. Duplicates IEA annotation with higher-quality ISS evidence.
- term:
id: GO:0035914
label: skeletal muscle cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. There is some evidence from mouse studies
for EGR2 involvement in jaw opener musculature development, but this is not well
characterized for human EGR2.
action: KEEP_AS_NON_CORE
reason: >-
Peripheral function. UniProt mentions a role in jaw opener musculature development by
similarity. This is not a core function and evidence in human is limited.
# ===== IDA annotations from PMID:17717711 =====
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: IDA
original_reference_id: PMID:17717711
review:
summary: >-
IDA annotation based on Szigeti et al. 2007, which characterized EGR2 mutations
functionally, demonstrating that wild-type EGR2 has DNA-binding transcription factor
activity and that disease mutations abolish this activity.
action: ACCEPT
reason: >-
Core molecular function supported by direct assay. The R359W and E412K mutations
caused loss of DNA binding and transactivation activity, confirming WT EGR2 has this
function.
supported_by:
- reference_id: PMID:17717711
supporting_text: >-
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and
related inherited peripheral neuropathies
- term:
id: GO:0043565
label: sequence-specific DNA binding
evidence_type: IDA
original_reference_id: PMID:17717711
review:
summary: >-
IDA annotation from functional characterization of EGR2 mutations. Disease mutations
in zinc finger domains abolished sequence-specific DNA binding, confirming wild-type
EGR2 binds DNA in a sequence-specific manner.
action: ACCEPT
reason: >-
Core molecular function. Direct assay evidence from functional studies of disease variants.
- term:
id: GO:0045944
label: positive regulation of transcription by RNA polymerase II
evidence_type: IDA
original_reference_id: PMID:17717711
review:
summary: >-
IDA annotation from functional characterization of EGR2. Wild-type EGR2 activates
pol II transcription; disease mutations cause loss of transactivation activity.
action: ACCEPT
reason: >-
Core function. Disease mutations (R359W, E412K) lost transactivation activity, confirming
WT EGR2 positively regulates pol II transcription.
# ===== ISA annotations =====
- term:
id: GO:0000785
label: chromatin
evidence_type: ISA
original_reference_id: GO_REF:0000113
review:
summary: >-
ISA annotation from TFClass database (tfclass:2.3.1, C2H2 zinc finger factors).
As a DNA-binding transcription factor, EGR2 localizes to chromatin at its target sites.
action: ACCEPT
reason: >-
Reasonable. TF annotation from TFClass. EGR2 binds to chromatin at cis-regulatory
elements of target genes.
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: ISA
original_reference_id: GO_REF:0000113
review:
summary: >-
ISA annotation from TFClass database classification of EGR2 as a C2H2 zinc finger
transcription factor (class 2.3.1).
action: ACCEPT
reason: >-
Core function. TFClass annotation consistent with all experimental evidence.
# ===== ISS annotations for sumoylation =====
- term:
id: GO:0016925
label: protein sumoylation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 participates in protein sumoylation
as an E3 SUMO ligase for NAB1/NAB2.
action: ACCEPT
reason: >-
Correct. Experimentally validated in PMID:21836637. The ISS annotation from mouse
is consistent with human experimental evidence.
supported_by:
- reference_id: PMID:21836637
supporting_text: >-
Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins
- term:
id: GO:0061665
label: SUMO ligase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 has E3 SUMO ligase activity,
transferring SUMO1 to NAB coregulators via UBC9.
action: ACCEPT
reason: >-
Core enzymatic function. Experimentally demonstrated in PMID:21836637 using human Krox20.
UniProt lists this as a confirmed activity with EC number.
supported_by:
- reference_id: PMID:21836637
supporting_text: >-
we show that Krox20 functions as a SUMO ligase for its coregulators--the Nab
proteins--and that Nab sumoylation negatively modulates Krox20 transcriptional
activity in vivo
# ===== IDA annotations from PMID:12687019 =====
- term:
id: GO:0000978
label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
evidence_type: IDA
original_reference_id: PMID:12687019
review:
summary: >-
IDA annotation from Unoki and Nakamura 2003, which showed EGR2 directly binds
promoter regions of BNIP3L and BAK to transactivate their expression.
action: ACCEPT
reason: >-
Core function. Direct assay evidence showing EGR2 binds cis-regulatory regions of
target genes and activates transcription.
supported_by:
- reference_id: PMID:12687019
supporting_text: >-
EGR2 directly transactivates expression of BNIP3L and BAK
- term:
id: GO:0001228
label: DNA-binding transcription activator activity, RNA polymerase II-specific
evidence_type: IDA
original_reference_id: PMID:12687019
review:
summary: >-
IDA annotation for transcription activator activity from the study showing EGR2
directly transactivates BNIP3L and BAK expression.
action: ACCEPT
reason: >-
Core molecular function. This is a more specific child of GO:0000981 and accurately
captures EGR2's role as a transcriptional activator. Consistent with the GO annotation
guidelines for DNA-binding transcription factors.
supported_by:
- reference_id: PMID:12687019
supporting_text: >-
EGR2 could induce apoptosis in a large proportion of these lines ... EGR2 directly
transactivates expression of BNIP3L and BAK
- term:
id: GO:0045944
label: positive regulation of transcription by RNA polymerase II
evidence_type: IDA
original_reference_id: PMID:12687019
review:
summary: >-
IDA annotation from the same study showing EGR2 positively regulates pol II
transcription of BNIP3L and BAK.
action: ACCEPT
reason: >-
Core function. Direct experimental evidence for transcriptional activation.
# ===== TAS annotations from Reactome =====
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9612073
review:
summary: >-
TAS annotation from Reactome pathway for NGF- and MAPK-dependent EGR1, EGR2 and EGR4
expression. Places EGR2 in the nucleoplasm.
action: ACCEPT
reason: >-
Correct localization. EGR2 functions in the nucleoplasm as a transcription factor.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9612483
review:
summary: >-
TAS annotation from Reactome for EGR1,2,3 binding the NAB2 promoter. EGR2 binds
the NAB2 promoter in the nucleoplasm.
action: ACCEPT
reason: >-
Correct. EGR2 regulates NAB2 expression as part of a negative feedback loop.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9613210
review:
summary: >-
TAS annotation from Reactome for EGR1, EGR2 binding the RRAD promoter.
action: ACCEPT
reason: >-
Correct localization for nucleoplasmic transcription factor activity.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9613213
review:
summary: >-
TAS annotation from Reactome for NAB2 and CHD4 binding and repressing EGR-mediated
RRAD gene expression.
action: ACCEPT
reason: >-
Correct. EGR2-mediated transcription occurs in the nucleoplasm, and NAB2/CHD4 repress
this activity.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9613476
review:
summary: >-
TAS annotation from Reactome for EGR2:NAB2 and CHD4 binding the ID2 and ID4 promoter
regions.
action: ACCEPT
reason: >-
Correct localization for EGR2 transcriptional activity.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9613760
review:
summary: >-
TAS annotation from Reactome for EGR2 gene expression.
action: ACCEPT
reason: >-
Correct. EGR2 protein functions in the nucleoplasm.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9616116
review:
summary: >-
TAS annotation from Reactome for EGR2 and SOX10 binding the MAG gene. This represents
a well-characterized myelin gene target.
action: ACCEPT
reason: >-
Correct. EGR2 cooperates with SOX10 to activate myelin gene expression in the
nucleoplasm.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9618559
review:
summary: >-
TAS annotation from Reactome for EGR2, SOX10 and TEAD1 binding enhancers in the PMP22
gene.
action: ACCEPT
reason: >-
Correct. PMP22 is a key myelin gene regulated by EGR2.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9618725
review:
summary: >-
TAS annotation from Reactome for SOX10, EGR2 and NAB proteins binding the GJB1 promoter.
action: ACCEPT
reason: >-
Correct. GJB1 (connexin 32) is another myelin gene target of EGR2.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9621400
review:
summary: >-
TAS annotation from Reactome for EGR2 and SREBF2 dimer binding SCD5 gene.
action: ACCEPT
reason: >-
Correct. EGR2 cooperates with SREBF2 to regulate lipid biosynthesis genes important
for myelin formation.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9621406
review:
summary: >-
TAS annotation from Reactome for EGR2 and SREBF2 dimer binding CYP51A1 gene.
action: ACCEPT
reason: >-
Correct. Another lipid biosynthesis gene regulated by EGR2 for myelin formation.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9621411
review:
summary: >-
TAS annotation from Reactome for EGR2 and SREBF2(1-484) dimer binding HMGCR gene.
action: ACCEPT
reason: >-
Correct. HMGCR encodes a cholesterol biosynthesis enzyme important for myelin lipid
composition.
# ===== Additional ISS annotations =====
- term:
id: GO:0000976
label: transcription cis-regulatory region binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 binds cis-regulatory regions in
promoters and enhancers of target genes.
action: ACCEPT
reason: >-
Correct. Parent term of more specific DNA binding annotations.
- term:
id: GO:0003682
label: chromatin binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse Egr2. EGR2 binds chromatin at regulatory elements.
action: ACCEPT
reason: >-
Correct. EGR2 binds chromatin in the context of regulating target gene expression.
- term:
id: GO:0005634
label: nucleus
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for nuclear localization transferred from mouse Egr2.
action: ACCEPT
reason: >-
Correct. Consistent with all other evidence.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for cytoplasmic localization from mouse Egr2.
action: KEEP_AS_NON_CORE
reason: >-
EGR2 is primarily nuclear. Cytoplasmic localization is likely transient.
- term:
id: GO:0006611
label: protein export from nucleus
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for nuclear export from mouse Egr2.
action: KEEP_AS_NON_CORE
reason: >-
Not core. Regulatory mechanism rather than primary function.
- term:
id: GO:0045893
label: positive regulation of DNA-templated transcription
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for positive regulation of transcription from mouse Egr2.
action: ACCEPT
reason: >-
Core function. EGR2 is primarily a transcriptional activator.
# ===== IC annotation =====
- term:
id: GO:0005634
label: nucleus
evidence_type: IC
original_reference_id: PMID:14532282
review:
summary: >-
IC (inferred by curator) annotation for nuclear localization, inferred from
DNA-binding transcription factor activity (GO:0003700) demonstrated in PMID:14532282
(HCF-1 as coactivator for Krox20).
action: ACCEPT
reason: >-
Correct inference. A DNA-binding transcription factor must be in the nucleus to function.
supported_by:
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation,
... showed a strong requirement for functional HCF-1 to activate transcription
# ===== Additional ISS annotations =====
- term:
id: GO:0045444
label: fat cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for fat cell differentiation from mouse Egr2.
action: KEEP_AS_NON_CORE
reason: >-
Peripheral function. Not a primary role for human EGR2.
- term:
id: GO:0061629
label: RNA polymerase II-specific DNA-binding transcription factor binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for TF binding from mouse Egr2. EGR2 interacts with other TFs and
coregulators including SOX10, HCFC1, NAB1/NAB2.
action: ACCEPT
reason: >-
Correct. EGR2 interacts with multiple TF-related proteins. HCFC1 interaction validated
experimentally (PMID:14532282).
# ===== IPI annotation =====
- term:
id: GO:0031625
label: ubiquitin protein ligase binding
evidence_type: IPI
original_reference_id: PMID:19651900
review:
summary: >-
IPI annotation showing EGR2 binds the E3 ubiquitin ligase WWP2 (AIP2, UniProtKB:O00308).
WWP2 ubiquitinates EGR2, leading to its proteasomal degradation, which regulates
activation-induced T cell death.
action: ACCEPT
reason: >-
Experimentally validated interaction. EGR2 is a substrate of the ubiquitin ligase WWP2,
and this interaction regulates EGR2 stability and consequently FasL expression in T cells.
supported_by:
- reference_id: PMID:19651900
supporting_text: >-
AIP2 interacts with and promotes ubiquitin-mediated degradation of EGR2, a zinc
finger transcription factor that has been found to regulate Fas ligand (FasL)
expression during activation-induced T-cell death
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:14532282
review:
summary: >-
IPI annotation for protein binding with HCFC1 (UniProtKB:P51610). EGR2 contains an
HCF-binding motif (DHLY at residues 162-165) that mediates interaction with HCFC1,
which functions as a coactivator for EGR2.
action: MODIFY
reason: >-
The term "protein binding" (GO:0005515) is too vague and uninformative. The interaction
with HCFC1 is functionally significant as a transcriptional coactivation interaction.
A more specific term should be used. The RNA polymerase II-specific DNA-binding
transcription factor binding (GO:0061629) already captures this type of interaction.
proposed_replacement_terms:
- id: GO:0061629
label: RNA polymerase II-specific DNA-binding transcription factor binding
supported_by:
- reference_id: PMID:14532282
supporting_text: >-
HCF-1 functions as a coactivator for the zinc finger protein Krox20 ... In Krox20,
the HCF-binding motif lies within the N-terminal activation domain and mutation of
this sequence diminishes both transactivation and association with the HCF-1
beta-propeller
# ===== Additional IDA annotations =====
- term:
id: GO:0003700
label: DNA-binding transcription factor activity
evidence_type: IDA
original_reference_id: PMID:14532282
review:
summary: >-
IDA annotation from Luciano and Wilson 2003. The study demonstrated EGR2/Krox20 has
transcription factor activity using reporter assays and showed that HCFC1 functions
as its coactivator.
action: ACCEPT
reason: >-
Core function. Direct assay evidence. While this is a parent of the more specific
GO:0000981, it is acceptable as a separate IDA annotation.
supported_by:
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation,
... showed a strong requirement for functional HCF-1 to activate transcription
# ===== TAS annotations from literature =====
- term:
id: GO:0007420
label: brain development
evidence_type: TAS
original_reference_id: PMID:9537424
review:
summary: >-
TAS annotation for brain development from Warner et al. 1998. EGR2 is involved in
hindbrain development through its role in rhombomere specification. Egr2 knockout mice
show disrupted hindbrain segmentation.
action: KEEP_AS_NON_CORE
reason: >-
Broad developmental term. EGR2 is specifically involved in hindbrain segmentation
rather than general brain development. The more specific rhombomere terms capture this
role better. Keeping as non-core.
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Egr2(-/-) mice display disrupted hindbrain segmentation and development
- term:
id: GO:0007422
label: peripheral nervous system development
evidence_type: TAS
original_reference_id: PMID:9537424
review:
summary: >-
TAS annotation for PNS development from Warner et al. 1998. EGR2 is critical for
peripheral nerve myelination. The paper identified EGR2 mutations in patients with
hereditary myelinopathies.
action: ACCEPT
reason: >-
Core biological process. EGR2 is essential for PNS development through its role in
Schwann cell myelination. Mutations cause inherited peripheral neuropathies.
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Stable expression of Egr2 is specifically associated with the onset of myelination
in the peripheral nervous system ... we have identified one recessive and two
dominant missense mutations in EGR2 ... in patients with congenital hypomyelinating
neuropathy (CHN) and a family with Charcot-Marie-Tooth type 1 (CMT1)
references:
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000113
title: Gene Ontology annotation of human sequence-specific DNA binding transcription
factors (DbTFs) based on the TFClass database
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12687019
title: EGR2 induces apoptosis in various cancer cell lines by direct transactivation
of BNIP3L and BAK.
findings:
- statement: >-
EGR2 directly transactivates expression of BNIP3L and BAK through binding to their
promoter regions, inducing apoptosis in cancer cell lines.
supporting_text: >-
EGR2 could induce apoptosis in a large proportion of these lines by altering the
permeability of mitochondrial membranes, releasing cytochrome c and activating
caspase-3, -8, and -9. Analysis by cDNA microarray and subsequent functional
studies revealed that EGR2 directly transactivates expression of BNIP3L and BAK.
- id: PMID:14532282
title: HCF-1 functions as a coactivator for the zinc finger protein Krox20.
findings:
- statement: >-
HCFC1 functions as a coactivator for EGR2/Krox20. The HCF-binding motif (DHLY at
residues 162-165) in EGR2 mediates interaction with the HCFC1 beta-propeller domain.
Mutation of this motif diminishes both transactivation and HCFC1 association.
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation,
and E2F4, a cell cycle regulator, showed a strong requirement for functional HCF-1
to activate transcription ... In Krox20, the HCF-binding motif lies within the
N-terminal activation domain and mutation of this sequence diminishes both
transactivation and association with the HCF-1 beta-propeller
- id: PMID:17717711
title: Functional, histopathologic and natural history study of neuropathy associated
with EGR2 mutations.
findings:
- statement: >-
Characterization of EGR2 mutations causing CMT1D/CHN/DSS. R359W and E412K mutations
cause loss of DNA binding and transactivation. I268N affects the NAB repressor binding
site. Cranial nerve dysfunction and respiratory compromise are common features.
supporting_text: >-
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and
related inherited peripheral neuropathies ... respiratory compromise and cranial
nerve dysfunction are commonly associated with EGR2 mutations
- id: PMID:19651900
title: The HECT-type E3 ubiquitin ligase AIP2 inhibits activation-induced T-cell
death by catalyzing EGR2 ubiquitination.
findings:
- statement: >-
WWP2/AIP2 interacts with and ubiquitinates EGR2, promoting its proteasomal degradation.
EGR2 regulates FasL expression in T cells during activation-induced cell death. AIP2-mediated
EGR2 degradation protects against T cell apoptosis.
supporting_text: >-
AIP2 interacts with and promotes ubiquitin-mediated degradation of EGR2, a zinc
finger transcription factor that has been found to regulate Fas ligand (FasL)
expression during activation-induced T-cell death
- id: PMID:21836637
title: The transcription factor Krox20 is an E3 ligase that sumoylates its Nab coregulators.
findings:
- statement: >-
EGR2/Krox20 functions as an E3 SUMO ligase, catalyzing SUMO1 conjugation to its NAB
coregulators. This requires interaction with the SUMO-conjugating enzyme UBC9. NAB
sumoylation negatively modulates EGR2 transcriptional activity.
supporting_text: >-
we show that Krox20 functions as a SUMO ligase for its coregulators--the Nab
proteins--and that Nab sumoylation negatively modulates Krox20 transcriptional
activity in vivo
- id: PMID:28473536
title: Impact of cytosine methylation on DNA binding specificities of human transcription
factors.
findings:
- statement: >-
Systematic SELEX analysis of 542 human TFs including EGR2 characterized binding
specificities on both unmethylated and CpG-methylated DNA.
supporting_text: >-
By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution
of ligands by exponential enrichment), we found that there are also many TFs
that prefer CpG-methylated sequences
- id: PMID:9537424
title: Mutations in the early growth response 2 (EGR2) gene are associated with
hereditary myelinopathies.
findings:
- statement: >-
First identification of EGR2 mutations causing human myelinopathies. Recessive and
dominant missense mutations found in patients with CHN and CMT1. Egr2 knockout mice
show disrupted hindbrain development and a block in Schwann cell differentiation.
supporting_text: >-
Stable expression of Egr2 is specifically associated with the onset of myelination
in the peripheral nervous system (PNS). Egr2(-/-) mice display disrupted hindbrain
segmentation and development, and a block of Schwann-cell differentiation at an
early stage
- id: Reactome:R-HSA-9612073
title: NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression
findings: []
- id: Reactome:R-HSA-9612483
title: EGR1,2,3 bind the NAB2 promoter
findings: []
- id: Reactome:R-HSA-9613210
title: EGR1, EGR2 bind the RRAD promoter
findings: []
- id: Reactome:R-HSA-9613213
title: NAB2 and CHD4 bind and repress EGR-mediated RRAD gene expression
findings: []
- id: Reactome:R-HSA-9613476
title: EGR2:NAB2 and CHD4 bind the ID2 and ID4 promoter regions
findings: []
- id: Reactome:R-HSA-9613760
title: EGR2 gene expression
findings: []
- id: Reactome:R-HSA-9616116
title: EGR2 and SOX10 bind the MAG gene
findings: []
- id: Reactome:R-HSA-9618559
title: EGR2, SOX10 and TEAD1 bind enhancers in the PMP22 gene
findings: []
- id: Reactome:R-HSA-9618725
title: SOX10, EGR2 and NAB proteins bind the GJB1 promoter
findings: []
- id: Reactome:R-HSA-9621400
title: EGR2 and SREBF2 dimer bind SCD5 gene
findings: []
- id: Reactome:R-HSA-9621406
title: EGR2 and SREBF2 dimer bind CYP51A1 gene
findings: []
- id: Reactome:R-HSA-9621411
title: EGR2 and SREBF2(1-484) dimer bind HMGCR gene
findings: []
- id: file:human/EGR2/EGR2-deep-research-falcon.md
title: Deep research report on EGR2 function (Falcon provider)
findings:
- statement: >-
EGR2 is a nuclear C2H2 zinc-finger transcription factor that binds GC-rich EGR
motifs and recruits NAB1/2 to activate or repress target genes, serving as a master
regulator of myelin programs in Schwann cells and a node in immune tolerance and
dysfunction circuits.
core_functions:
- description: >-
DNA-binding transcription activator activity: EGR2 enables DNA-binding transcription
activator activity, RNA polymerase II-specific (GO:0001228). It binds GC-rich EGR consensus
sequences (5'-GCGGGGGCG-3') through three C2H2 zinc finger domains and activates transcription
of target genes in the nucleus. Key direct targets include myelin structural genes (MPZ,
PMP22, GJB1, MAG), HOX genes (HOXB2, HOXB3, HOXA4), NAB2, BNIP3L, and BAK.
molecular_function:
id: GO:0001228
label: DNA-binding transcription activator activity, RNA polymerase II-specific
directly_involved_in:
- id: GO:0045944
label: positive regulation of transcription by RNA polymerase II
locations:
- id: GO:0005634
label: nucleus
supported_by:
- reference_id: PMID:17717711
supporting_text: >-
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and
related inherited peripheral neuropathies
- reference_id: PMID:12687019
supporting_text: >-
EGR2 directly transactivates expression of BNIP3L and BAK
- reference_id: PMID:14532282
supporting_text: >-
Krox20, a zinc finger transcription factor required for Schwann cell differentiation,
and E2F4, a cell cycle regulator, showed a strong requirement for functional HCF-1
to activate transcription
- description: >-
E3 SUMO ligase activity: EGR2 enables SUMO ligase activity (GO:0061665), catalyzing
transfer of SUMO1 to its NAB1 and NAB2 coregulators in collaboration with the SUMO-conjugating
enzyme UBC9. NAB sumoylation negatively modulates EGR2 transcriptional activity, providing
a negative feedback mechanism.
molecular_function:
id: GO:0061665
label: SUMO ligase activity
directly_involved_in:
- id: GO:0016925
label: protein sumoylation
locations:
- id: GO:0005634
label: nucleus
supported_by:
- reference_id: PMID:21836637
supporting_text: >-
we show that Krox20 functions as a SUMO ligase for its coregulators--the Nab
proteins--and that Nab sumoylation negatively modulates Krox20 transcriptional
activity in vivo
- description: >-
Positive regulation of Schwann cell myelination: EGR2 is a master regulator of peripheral
nervous system myelination. It promotes Schwann cell differentiation from the premyelinating
to the myelinating state, activating myelin structural genes (MPZ, PMP22, GJB1, MAG)
cooperatively with SOX10 and lipid biosynthesis genes (SCD5, CYP51A1, HMGCR) with SREBF2.
Loss-of-function mutations cause Charcot-Marie-Tooth disease type 1D, Dejerine-Sottas
syndrome, and congenital hypomyelinating neuropathy.
molecular_function:
id: GO:0001228
label: DNA-binding transcription activator activity, RNA polymerase II-specific
directly_involved_in:
- id: GO:0031643
label: positive regulation of myelination
- id: GO:0014040
label: positive regulation of Schwann cell differentiation
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Stable expression of Egr2 is specifically associated with the onset of myelination
in the peripheral nervous system (PNS). Egr2(-/-) mice display disrupted hindbrain
segmentation and development, and a block of Schwann-cell differentiation at an
early stage
- reference_id: PMID:17717711
supporting_text: >-
Mutations in the EGR2 gene cause a spectrum of Charcot-Marie-Tooth disease and
related inherited peripheral neuropathies
- description: >-
Hindbrain segmentation: EGR2 is specifically expressed in and required for proper
specification of rhombomeres 3 and 5 during hindbrain development, controlling expression
of HOX genes (HOXB2, HOXB3, HOXA4) that specify rhombomere identity. This is a conserved
developmental function.
molecular_function:
id: GO:0001228
label: DNA-binding transcription activator activity, RNA polymerase II-specific
directly_involved_in:
- id: GO:0035284
label: brain segmentation
supported_by:
- reference_id: PMID:9537424
supporting_text: >-
Egr2(-/-) mice display disrupted hindbrain segmentation and development